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Background
As housestaff, we seldom have the chance to admit a patient
with cancer of unknown primary. Even if a patient presents
with metastatic cancer, it is frequently evident what the primary
cancer is based on epidemiology and imaging. However, in this
case we have the unique opportunity of describing a metastatic
cancer that presented as a lip carcinoma with several possible
primary sources. Our goal is to guide the reader through
the thought process involved with determining the primary
malignancy in patients presenting with metastatic disease.

Case Presentation
A 54-year-old female with a 30-pack-year smoking history
presented to the emergency department with pain and swelling
of the right lower lip. The symptoms started one month ago
with mild to moderate pain, and progressed within one week to
significant swelling. She had developed a lip abscess two weeks
prior that was incised and drained, but now presented with
worsening drainage, swelling, and pain. She also had fevers and
a non-productive cough for one month.

Investigation
On admission to the hospital, the patient was afebrile and had
normal vital signs. Her right lower lip was noted to be indurated,
with no fluctuance. There was no area of warmth or erythema
surrounding the area of induration. Admission labs were
within normal limits. Initial chest x-ray revealed consolidation
within the right middle lobe and right lower lobe, as well as a
moderate right pleural effusion. Maxillofacial CT with contrast
revealed an organized rim-enhancing fluid collection within
the soft tissues overlying the right mandible with overlying
skin ulceration and surrounding inflammatory changes in the
adjacent subcutaneous tissues.

Hospital Course
The initial differential diagnosis of the patient’s lip lesion
included abscess, cellulitis, and malignancy. On admission, she
was empirically treated for cellulitis and community acquired
pneumonia. On hospital day 2 she was taken for a lip biopsy,
which revealed ulcerated lesions with clusters of markedly
atypical cells, most consistent with an ulcerated squamous cell
carcinoma (SQCC). Immunohistochemistry stains showed that
the tumor cells were positive for cytokeratin CK7 and negative
for CK20, TTF1/Napsin, CK5/6 and mucicarmine. These were
not consistent with a cutaneous SQCC as will be discussed

Published by Jefferson Digital Commons, 2013

Figure 1. CXR: Apparent widening of the superior
mediastinum. Mild atelectasis in the left midlung is noted.
later on. These results necessitated a metastatic workup to
determine the primary source. A CT of the chest was obtained
which showed a large right hilar mass, a new spiculated 7mm
nodule in the inferior left lower lobe, and new mediastinal and
hilar adenopathy. It also showed a large hypodense lesion with
irregular margins within the right hepatic lobe. Based on these
findings, a fine needle aspiration of the lung was obtained. The
immunohistochemistry of the lesion matched that of the lip.
These findings favored a diagnosis of primary lung cancer with
metastasis to the lip, but could also represent either unknown
primary or synchronous malignancies. Primary squamous cell
carcinoma of the lip was deemed unlikely since these cancers
are most often CK7 negative. Based on these findings, the
decision was made by the primary oncologist to go forward
with treatment of primary lung cancer, and platinum based
chemotherapy was initiated.

Discussion
In the initial approach to a cancer of unknown primary, an
evaluation of immunohistochemical markers can help narrow
the list of possible cancers. The first step is often to stain for
cytokeratins, specifically CK7 and CK20. The patient tested
positive for CK7, and negative for CK20, which could indicate
any of the following cancers: non-small cell lung, small cell lung,
breast, endometrial, nonmucinous ovarian, mesothelioma,
and squamous cervical carcinoma.1 In general, CK7+/CK20strongly favors lung carcinoma.2 After a metastatic workup with
imaging that yielded a lung and liver nodule, it was thought that
the lip lesion was most metastatic from the lung.
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Further analysis of the lesion involved lung cancer specific
markers. Napsin and TTF1 are markers for lung adenocarcinoma (ADC) and both used in conjunction have 74%
sensitivity and 87% specificity for ADC. 3 These were both
negative indicating a low likelihood of lung ADC. Additionally,
p63 and CK5/6 markers were analyzed, which are used for
distinguishing SQCC from ADC of the lung. ADC does not
express either marker, whereas SQCC has approximately 75%
chance of positive expressivity. Virtually all ADC and SQCC
will not express CK20.4
Metastatic carcinomas tend to be poorly differentiated, as is
the case with this patient. Unfortunately, the immunohistochemistry of this particular carcinoma does not strongly favor
ADC or SQCC; however, the histology more closely resembles
poorly differentiated SQCC. At this time, the diagnosis favors a
lung SQCC metastatic to the skin of the face.

Key Points
A thorough pathological examination is important in the
diagnosis and treatment of tumors of unknown primary.
Important components of this examination include cytokeratin
markers CK7 and CK20, as well as other markers such as TTF1,
Napsin, CD5/6 and mucicarmine. Further analysis depends
largely on the clinical picture. For our patient, a closer look at
her long smoking history along with the information gathered
from cytopathology favored a diagnosis of lung cancer, and
appropriate treatment was given.
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